PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: stock market

TRADEMARK (GALANTAMINE HBR) EXTENDED-RELEASE …

TRADEMARK (GALANTAMINE HBR) EXTENDED-RELEASE CAPSULES DESCRIPTION TRADEMARK (galantamine hydrobromide) is a reversible, competitive acetylcholinesterase inhibitor. It is known chemically as (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide. It has an empirical formula of C 17H 21NO

Fullscreen Download

Tags:

  Release, Capsule, Trademark, Extended, Extended release, Galantamine hbr, Galantamine, Extended release capsules

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Documents from same domain

Namenda XR (memantine hydrochloride) capsules …

www.accessdata.fda.gov

The most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the

  Clinical, Capsule, Hydrochloride, Namenda xr, Namenda, Memantine hydrochloride, Memantine

Effexor (venlafaxine hydrochloride) Tablets …

www.accessdata.fda.gov

Effexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …

  Tablets, Antidepressant, Effexor, Venlafaxine hydrochloride, Venlafaxine, Hydrochloride

Reference ID: 3101735 - Food and Drug …

www.accessdata.fda.gov

Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.

  Drug, Food, Food and drug

Cytotec® - Food and Drug Administration

www.accessdata.fda.gov

cytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.

  Administration, Drug, Food and drug administration, Food, Cytotec

HIGHLIGHTS OF PRESCRIBING INFORMATION …

www.accessdata.fda.gov

weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …

  Breathing

FOR INTRAVENOUS USE ONLY - Food and Drug …

www.accessdata.fda.gov

NDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of

  Drug, Food, Food and drug, Only, Intravenous, For intravenous use only

NOT FOR USE IN NEONATES CONTAINS BENZYL …

www.accessdata.fda.gov

Depo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION

  Alcohols, Neonates, Contains, In neonates contains benzyl, Benzyl, In neonates contains benzyl alcohol

HIGHLIGHTS OF PRESCRIBING INFORMATION …

www.accessdata.fda.gov

Dacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …

Venofer - Food and Drug Administration

www.accessdata.fda.gov

NDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …

  Administration, Drug, Food and drug administration, Food, Only, Venofer

Diphenhydramine Hydrochloride Injection

www.accessdata.fda.gov

HOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.

  Diphenhydramine